ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 108 filers reported holding ALBIREO PHARMA INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $485 | -99.9% | 22,452 | +5.4% | 0.00% | 0.0% |
Q3 2022 | $412,000 | +4.3% | 21,297 | +7.2% | 0.00% | 0.0% |
Q2 2022 | $395,000 | -26.3% | 19,873 | +10.6% | 0.00% | 0.0% |
Q1 2022 | $536,000 | +29.8% | 17,970 | +1.2% | 0.00% | 0.0% |
Q4 2021 | $413,000 | -26.6% | 17,754 | -1.7% | 0.00% | 0.0% |
Q3 2021 | $563,000 | -8.3% | 18,060 | +3.4% | 0.00% | 0.0% |
Q2 2021 | $614,000 | -7.3% | 17,459 | -7.0% | 0.00% | 0.0% |
Q1 2021 | $662,000 | -10.5% | 18,766 | -4.9% | 0.00% | 0.0% |
Q4 2020 | $740,000 | +38.8% | 19,736 | +23.5% | 0.00% | 0.0% |
Q3 2020 | $533,000 | +16.6% | 15,979 | -7.3% | 0.00% | 0.0% |
Q2 2020 | $457,000 | +102.2% | 17,242 | +25.0% | 0.00% | – |
Q1 2020 | $226,000 | -32.9% | 13,797 | +4.2% | 0.00% | -100.0% |
Q4 2019 | $337,000 | +28.1% | 13,242 | +0.7% | 0.00% | – |
Q3 2019 | $263,000 | -37.5% | 13,150 | +0.8% | 0.00% | -100.0% |
Q2 2019 | $421,000 | +1.2% | 13,050 | +1.1% | 0.00% | 0.0% |
Q1 2019 | $416,000 | +30.0% | 12,906 | -1.1% | 0.00% | 0.0% |
Q4 2018 | $320,000 | +4.2% | 13,056 | +40.2% | 0.00% | 0.0% |
Q3 2018 | $307,000 | -8.4% | 9,313 | -1.3% | 0.00% | 0.0% |
Q2 2018 | $335,000 | – | 9,438 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |